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Identification of complex molecular networks under-
lying common human phenotypes is a major chal-
lenge of modern genetics. In this study, we develop
a method for network-based analysis of genetic
associations (NETBAG). We use NETBAG to identify
a large biological network of genes affected by rare
de novo CNVs in autism. The genes forming the
network are primarily related to synapse develop-
ment, axon targeting, and neuronmotility. The identi-
fied network is strongly related to genes previously
implicated in autism and intellectual disability pheno-
types.Our results are alsoconsistentwith thehypoth-
esis that significantly stronger functional perturba-
tions are required to trigger the autistic phenotype
in females compared tomales. Overall, the presented
analysis of de novo variants supports the hypothesis
that perturbed synaptogenesis is at the heart of
autism. More generally, our study provides proof of
the principle that networks underlying complex
human phenotypes can be identified by a network-
based functional analysis of rare genetic variants.
INTRODUCTION
The ongoing revolution in genomic and sequencing technologies
has allowed researchers to routinely perform genome-wide
association studies (GWAS) for multiple common human
diseases and phenotypes (Frazer et al., 2007; Hardy and
Singleton, 2009). Although these studies have successfully iden-
tified hundreds of significant associations, common polymor-
phisms reaching genome-wide significance usually explain
a relatively small fraction of disease heritability (Goldstein,
2009). There is a growing consensus in genetics that the most
valuable contribution of GWAS studies will be in the identification
of functional pathways underlying the observed phenotypes
(Hirschhorn, 2009). In addition, it is likely that a significant frac-
tion of so-called missing heritability (Manolio et al., 2009), which
has eluded association studies, is accounted for by rare single898 Neuron 70, 898–907, June 9, 2011 ª2011 Elsevier Inc.nucleotide mutations and structural genomic variations (McClel-
lan and King, 2010).
A notable example of a disease with a very complex allelic
architecture is autism—one of the most common neurological
disorders (Geschwind, 2008). Autism spectrum disorders are
characterized by impaired social interactions, abnormal verbal
communication, restricted interests, and repetitive behaviors.
Due in part to better detection strategies, the combined preva-
lence of ASD has been steadily increasing for several decades
and is nowapproachinga staggering1% in the humanpopulation.
Although autism has a very strong genetic component, with an
estimatedheritability ashighas90%basedonstudies ofmonozy-
gotic twins (Hyman, 2008), GWAS-based searches have impli-
catedonlya fewgenes that are associatedwithcommonpolymor-
phisms reaching genome-wide significance (Wang et al., 2009;
Weiss et al., 2009). In addition, the agreement between published
findings remainspoor (Manolio et al., 2009) andunderlyinggenetic
determinants for this disease still remain largely unknown. Impor-
tantly, there isgrowingevidence that rare sequencemutationsand
de novo copy number variations (CNVs) (Marshall et al., 2008;
Moessner et al., 2007; Pinto et al., 2010; Sebat et al., 2007) signif-
icantly contribute to autism etiology (Zhao et al., 2007).
The main challenge in the analysis of rare genetic variations,
such as de novo CNVs, is precisely their rarity, i.e., the fact
that a vast majority of the observed genetic events are unique.
Consequently, each rare variant by itself is not statistically signif-
icant, so an integrative conceptual framework is required to
understand their overall functional impact. We hypothesized
that recently obtained genome-wide de novo CNV data (Levy
et al., 2011) could allow identification of the underlying biological
pathways and processes if considered in the context of func-
tional biological networks (Feldman et al., 2008; Iossifov et al.,
2008). Here, we develop a method for network-based analysis
of genetic associations (NETBAG) and demonstrate its utility in
autism. The presented approach can determine whether the
observed rare events en masse affect a significantly intercon-
nected functional network of human genes.
RESULTS
NETBAG Method Overview
To implement our approach, we first built a background network
that connects any pair of human genes with a weighted edge
Figure 1. Outline of the NETwork-Based Analysis of Genetic Associations (NETBAG), the Method Used in Our Study to Identify Significant
and Functionally Related Gene Networks Affected by De Novo CNV Events
(A) A background network of human genes is constructed in which nodes indicate genes and edges represent the likelihood that two genes participate in the same
genetic phenotype.
(B) One or two genes are selected from each of de novo CNV region to form a cluster. The genes are mapped to the likelihood network and a combined score is
calculated for each cluster based on interactions between its genes.
(C) A greedy search procedure is used to identify the cluster with maximal score.
(D) The significance of the cluster with maximum score is determined by comparing it to the distribution of maximal scores from randomly selected genomic
regions with similar gene counts.
See Figure S1 for a further description of the NETBAG approach.
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ipate in the same genetic phenotype (see Experimental Proce-
dures and Supplemental Experimental Procedures). This back-
ground network was based on a combination of various
functional descriptors, such as shared gene ontology (GO) anno-
tations (Ashburner et al., 2000), functional pathways in KEGG
(Kanehisa and Goto, 2000), shared interaction partners and
coevolutionary patterns (see Experimental Procedures). Similar
methods have been previously used to build functional networks
in humans and several model organisms (Lee et al., 2004, 2008).
In contrast to the aforementioned studies, edges in our network
represent the likelihood that two genes participate in a similar
genetic phenotype rather than necessarily share cellular func-
tions. Importantly, no deliberate biases toward genes previously
implicated in autism or biological functions related to nervous
system were used in building the network. The likelihood
network was assembled using a large set of known disease-gene associations that were carefully curated for our previous
study (Feldman et al., 2008). This set contains 476 genes asso-
ciated with 132 different genetic diseases (see Experimental
Procedures).
Using the constructed network, we searched for functionally
connected clusters of human genes affected by de novo CNVs
(Figure 1). The genes within the observed CNV regions were first
mapped to the nodes corresponding to these genes in the
network (Figure 1B). Clusters of genes were assigned scores
based on the strength of their connections, and a greedy search
algorithm (see Experimental Procedures) was then used to find
high-scoring clusters of genes within the CNV regions (Fig-
ure 1C). In this search procedure genes from any CNV region
could be selected to be members of the growing cluster (Fig-
ure 1C), but to prevent large CNV regions from dominating clus-
ters, we allowed no more than one or two genes from a given
CNV to participate in a cluster (Figures 2A and 2B, respectively).Neuron 70, 898–907, June 9, 2011 ª2011 Elsevier Inc. 899
Figure 2. Gene Clusters Found using NETBAG Analysis of De Novo CNV Regions Observed in Autistic Individuals
(A) The highest scoring cluster obtained using the search procedure with up to one gene per each CNV region.
(B) The cluster obtained using the search with up to two genes per region. In the figure, genes (nodes) with known functions in the brain and nervous systems are
colored in orange (see Table S2 for functional information about the genes forming the cluster). Node sizes represent the importance of each gene to the overall
cluster score. Edgewidths are proportional to the prior likelihood that the two corresponding genes contribute to a shared genetic phenotype. For clarity, we show
only edges corresponding to the two strongest connections for at least one node.
See also Figure S2, Table S1, and Table S2.
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likelihood-based edges between all genes within the cluster.
Such a scoring scheme is conceptually equivalent to calcu-
lating the expected likelihood that all genes within the cluster
will participate in the same genetic phenotype. To account
for the fact that functional interactions between genes in
a cluster are not independent, we employed a previously devel-
oped de-weighting heuristic (Lee et al., 2004) described in the
Experimental Procedures; similar results were obtained with or
without the deweighting procedure (see Table S1). To calculate
the p value for the resulting clusters, random events were
generated with the same gene count or alternatively with the
same genomic length, as in the observed de novo CNV
dataset. The greedy algorithm was then applied to search for
high-scoring clusters formed by genes from these random
events. p values were assigned to clusters based on the distri-
bution of scores in the randomized data clusters (see Experi-
mental Procedures).
We and others have previously used various network-based
methods to analyze genetic data from rare and common
diseases (Feldman et al., 2008; Franke et al., 2006; Iossifov
et al., 2008, 2009; Lango Allen et al., 2010; Raychaudhuri et al.,
2009). NETBAG differs from the previous approaches in several
important ways. Specifically, the underlying weighted network
does not represent a molecular interaction network or a set of
predefined functional pathways, but instead the prior likelihood
that any pair of human genes is involved in the same genetic
phenotype. NETBAG then defines a formal procedure for identi-
fying strongly connected clusters among a large set of geneti-
cally perturbed genes and evaluating the genome-wide cluster
significance. The relative importance of specific genes forming
a cluster is then evaluated based on the contribution of genes900 Neuron 70, 898–907, June 9, 2011 ª2011 Elsevier Inc.to the overall cluster score. We are currently working on making
the NETBAGmethod available as a web server; in the meantime,
we will be happy to share the developed methodology with any
interested parties.
Functional Gene Network Identified from Rare De Novo
CNVs
The NETBAG approach was directly applied to the experimental
CNV dataset described in the companion paper by Levy et al.
(2011; this issue of Neuron). This set contained 75 rare de novo
CNVs encompassing 746 unique human genes. For our analysis,
we combined all overlapping events into a single region and
removed all events that did not intersect any genes; we also
removed six very large CNV events (length >5 mb). As a result,
the final set used for our analysis contained 47 CNV regions
from affected individuals intersecting 433 genes. In addition,
Levy et al. (2011) also identified ultrarare CNVs inherited by
autistic subjects but not their siblings; inherited CNVs were clas-
sified as ultrarare if at least one of the corresponding genes was
not affected by any other event from the study. Applying the
same preprocessing procedure resulted in 156 CNV regions
with 419 genes associated with rare inherited events in autistic
children.
Using the data described above, we identified statistically
significant gene clusters affected by de novo CNV events asso-
ciated with autistic individuals. Significant clusters detected
using either one-gene-per-CNV (p value = 0.02) or the two-
genes-per-CNV (p value = 0.02) clustering are shown in Figure 2.
If genes forming the high scoring clusters weremasked, no other
significant clusters were detected in the data.
In contrast, no statistically significant clusters were obtained
using ultrarare inherited CNVs from affected individuals (the
Neuron
Rare CNV Variants in Autism Perturb Synaptogenesisbest cluster p value = 0.6) The absence of a significant cluster in
the ultrarare inherited data set, which had a comparable number
of genes to the de novo events, suggests that the inherited CNVs
contain a significantly smaller fraction of casual genes, i.e.,
genes associated with autistic phenotype. This conclusion is
also supported by the observation by Levy et al. (2011) that there
is less bias in transmission of ultrarare inherited events. In other
words, autistic children were almost as likely as their unaffected
siblings to inherit an ultrarare event. This is in sharp contrast to
the de novo events, which were nearly four times more frequent
in the autistic children (7.9% in autistic children versus 2.0% in
unaffected siblings).
The contribution of each gene to the cluster score, i.e., its
functional connection to other cluster genes, is not uniform. To
capture each gene’s contribution to the cluster score we per-
formed Markov Chain Monte Carlo (MCMC) simulations,
sampling clusters based on their scores. The size of each gene
(node) in Figure 2 is proportional to the each gene’s membership
in high-scoring clusters during the sampling simulations (see
Experimental Procedures, Supplemental Experimental Proce-
dures). Similar node sizes were also obtained based on the
average connection strength from each gene to the other genes
in the cluster (Pearson’s r = 0.8, p value = 4*1011).
Interestingly, we found that genes affected by de novo CNVs
observed in females are significantly more important for the
overall cluster score than genes affected by CNVs in males,
i.e., female genes have stronger average connections with other
genes from the identified network (see Figure S2; one-tail Mann-
Whitney test, female >male, p value = 0.013). This observation is
illuminating because one of the striking phenotypic characteris-
tics of autism is the male-to-female incidence ratio of more than
5:1 for high-functioning ASD (Newschaffer et al., 2007). It has
been previously suggested (Zhao et al., 2007) that stronger
genetic perturbations are required, on average, to trigger an
autistic phenotype in females than males due to currently
unknown compensatory mechanisms. Two mechanisms may
lead to stronger perturbations in females: CNVs encompassing
a larger number of genes that are associated with ASD and
CNVs intersecting individual genes that produce a more delete-
rious impact when disrupted. The analysis of de novo events in
affected individuals lends support to both of these mechanisms:
the CNVs in females are indeed significantly larger (with median
of 10 genes per CNV in females, three genes per CNV in males,
two-tail Mann Whitney, p value = 0.02), and genes derived
from female CNVs are more functionally important for the
network shown in Figure 2. Using simulations of random CNVs
we also confirmed that the difference in the relative importance
of female versus male nodes is unlikely (p = 0.024) to be a simple
consequence of the larger CNV sizes in females (see Supple-
mental Information; Figure S2C). We believe that both of the
aforementioned mechanisms are at play. Indeed, it would be
surprising that stronger perturbation can be inflicted exclusively
by larger CNVs and not disruption of high impact genes, and vice
versa.
Functional Characterization of the Identified Network
Analysis of the established annotation resources, such as Swiss-
Prot (UniProt Consortium, 2007), GeneCards (www.genecards.org), WikiGenes (www.wikigenes.org), and IHOP (Hoffmann
and Valencia, 2004), suggests that a significant fraction of genes
in the identified network either play a well-defined functional
role in the brain or have been previously implicated in neurode-
generative and psychiatric disorders. Only 25% (54 of a
randomly selected 214) of all genes within the de novo CNV
regions have been previously associated with brain-related
phenotypes. However, when we consider genes in the identified
clusters this proportion rises drastically (p value < 103), to
67% (Figure 2A; 30 out of 45) for the one-gene-per-CNV cluster
or 52% (Figure 2B; 38 out of 72) for the two-genes-per-
CNV cluster (see Table S2 for functional description of cluster
genes).
To characterize in more detail the specific biological
processes related to the cluster in Figure 2A, we investigated
the strength of functional interactions between the cluster genes
and various gene ontology (GO) categories (Ashburner et al.,
2000). GO categories represent a curated set of functionally
related genes described by a controlled vocabulary. For human
genes in each of 1454GOcategories we calculated their average
log likelihood interaction score (using the background network)
with the genes in the identified cluster (Figure 2). TheGO-specific
significance of these interaction scores was calculated by
comparison with scores of randomly generated CNV events
with the same gene count at in real data by Levy et al. (2011).
A false discovery rate (FDR) procedure was used to correct for
multiple hypothesis testing (see Experimental Procedures). The
25 GO categories with lowest Q values, indicating the highest
connection significance to the autism associated cluster, are
shown in Table 1 (see Table S3 for other significant GO cate-
gories). These GO categories are primarily related to actin
network dynamics and reorganization, synaptogenesis, axono-
genesis, cell-cell adhesion, small GTPase signaling, and neurite
development. Consequently, the identified functional network is
associated with a diverse collection of molecular and cellular
processes essential for proper synaptogenesis and axon guid-
ance.We note that is it not possible to obtain the same functional
results by a statistical analysis of significantly overrepresented
GO terms for all 433 gene within the de novo CNVs from affected
individuals (see Supplemental Experimental Procedures for
details). The significant GO terms presented in Table 1 specifi-
cally describe the functional connection of the network in
Figure 2.
Using the same methodology, we found that the cluster in Fig-
ure 2A is strongly related to the set of genes previously impli-
cated in autism (p value = 0.001; see Supplemental Experimental
Procedures) and genes associated with intellectual disability
phenotypes (p value = 0.017). The collections of genes respon-
sible for these phenotypes were manually compiled recently by
Pinto et al. (2010) through an extensive review of the literature
and available databases. In spite of strong functional connec-
tions, the overlap between genes in the aforementioned sets
and the genes identified in our analysis is relatively small
(3%). Thus, our study significantly expands the collection of
genes implicated in ASD. The cluster genes are also strongly
connected (p value = 0.013) to proteins identified experimentally
by recent proteomic profiling of postsynaptic density (PSD) from
human neocortex (Baye´s et al., 2011).Neuron 70, 898–907, June 9, 2011 ª2011 Elsevier Inc. 901
Table 1. Gene Ontology (GO) Terms Highly Connected to the
Functional Network in Figure 2A
Gene Ontology Term GO Category Q Value
GO:0007015: actin filament
organization
Biological process <0.01
GO:0030424: axon Cellular component <0.01
GO:0048469: cell maturation Biological process <0.01
GO:0007611: learning and
or memory
Biological process <0.01
GO:0044456: synapse part Cellular component <0.01
GO:0045202: synapse Cellular component <0.01
GO:0007163: establishment and
or maintenance of cell polarity
Biological process 0.01
GO:0045216: intercellular junction
assembly and maintenance
Biological process 0.01
GO:0019201: nucleotide kinase
activity
Molecular function 0.01
GO:0005912: adherens junction Cellular component 0.01
GO:0007409: axonogenesis Biological process 0.01
GO:0016323: basolateral plasma
membrane
Cellular component 0.01
GO:0030041: actin filament
polymerization
Biological process 0.01
GO:0051258: protein polymerization Biological process 0.01
GO:0021700: developmental
maturation
Biological process 0.01
GO:0030863: cortical cytoskeleton Cellular component 0.01
GO:0000904: cellular morphogenesis
during differentiation
Biological process 0.01
GO:0005925: focal adhesion Cellular component 0.01
GO:0030427: site of polarized growth Cellular component 0.01
GO:0032271: regulation of protein
polymerization
Biological process 0.01
GO:0031175: neurite development Biological process 0.01
GO:0048666: neuron development Biological process 0.01
GO:0030055: cell matrix junction Cellular component 0.01
GO:0030832: regulation of actin
filament length
Biological process 0.01
GO:0030036: actin cytoskeleton
organization and biogenesis
Biological process 0.01
We defined a score that reflects the degree to which the network genes
interact with gene sets assigned to various GO categories (1454 in total).
For every GO category, a background distribution was built by generating
clusters from randomly chosen CNV regions with the same gene count as
observed in real data by Levy et al. (2011). These distributions were used
to derive false discovery rate (FDR) corrected Q values accounting for the
multiple hypothesis tests (one test for every GO gene set; see Experi-
mental Procedures). See also Table S3.
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At the core of the processes listed in Table 1 is the development
and maturation of synaptic contacts in the brain. The functional
relationships between proteins in the identified cluster can be
better appreciated if considered in the context ofmolecular inter-902 Neuron 70, 898–907, June 9, 2011 ª2011 Elsevier Inc.actions involved in formation and maturation of the excitatory
(glutamatergic) synapse (Figure 3). The excitatory synaptic
connections are formed between axons and dendritic spines,
which are complex and dynamic postsynaptic structures con-
taining thousands of different proteins (Alvarez and Sabatini,
2007; Tada and Sheng, 2006). The formation, maturation and
elimination of dendritic spines lie at the core of synaptic trans-
mission and memory formation (Roberts et al., 2010; Yang
et al., 2009). In Figure 3 the genes that are members of the iden-
tified network are shown in yellow, other functionally related
genes within rare de novo CNV regions from Levy et al. (2011)
are in blue and genes previously implicated or discussed in the
context of autism are highlighted using orange borders. Although
the picture shows a dense and interconnected web of molecular
interactions, the processes depicted in the figure can be under-
stood in terms of several signaling and structural pathways.
Many of these pathways ultimately converge on the regulation
of the growth and branching of the actin filament network, which
is essential for spine structural remodeling and morphogenesis.
The initial contacts between axons and dendrites are medi-
ated by specific adhesion-related proteins, such as neurexin
and neuroligin (e.g., NRXN1 and NLGN3, genes perturbed by
rare de novo CNVs associated with ASD are underlined here
and below) (Su¨dhof, 2008). On the postsynaptic side of an excit-
atory synapse, the initial axon-dendrite contacts ultimately
develop into a complex and dense structure, the postsynaptic
density (PSD), dominated by several types of glutamate recep-
tors (such as AMPA and NMDA), various scaffolding proteins
(DLG4/PSD95, DLG2, SHANK2/3, SynGAP1, DLGAP2) and traf-
ficking/signaling proteins (CTNND2). In total, the PSD contains
many hundreds of distinct proteins (Baye´s et al., 2011; Sheng
and Hoogenraad, 2007). Information for activity-dependent
regulation of spine morphology is passed through an interme-
diate level of signaling protein, such as Rho family (Linseman
and Loucks, 2008) of small GTPases (RhoA/B, Cdc42, Rac1) to
downstream targets (LIMK1 and PAK1/2/3) connected to
proteins modifying morphology of the actin network (cofilin and
Arp2/3) (Blanchoin et al., 2000). The activity of the GTPases is
regulated pre- or postsynaptically by many guanine exchange
factors (GEFs), GDP dissociation inhibitors (GDIs, such as
GDI1) and GTP-activating proteins (GAPs). Many other proteins
shown in Figure 3, such as FLNA, CTNNA3, DOCK8, SPTAN1,
CYFIP1, either bind directly to the actin network or mediate inter-
action of actin filaments with other proteins.
The WNT signaling pathway plays a crucial role in diverse
processes associated with formation of neural circuits (Salinas
and Zou, 2008). This pathway is also known to be directly
involved in the regulation of dendrite morphogenesis (Rosso
et al., 2005; Salinas et al., 1994). WNT signaling is accomplished
through the canonical branch (DVL,AXIN1, beta-catenin) and the
noncanonical branch (DVL1/2/3, Rac1, and JNK); both of these
pathway branches converge on regulation of actin network
morphogenesis. Similar to WNT, the reelin signaling also plays
a prominent role in the context of autism phenotype and specif-
ically dendritic spine morphogenesis (Fatemi et al., 2005; Niu
et al., 2008). Signaling by secreted extracellular RELN protein
acts though VLDR and Apoer2 receptors and the PI3K/Akt
pathway (Jossin and Goffinet, 2007) regulating the mammalian
Figure 3. Genes Associated with the Morphogenesis of Dendritic Spines
Dendritic spines are dynamically forming protrusions from a neuron’s dendrite which mediate excitatory connection to axons and determine synaptic strength.
The proteins shown in the figure play crucial roles in formation of physical contacts between axons and dendrites, organization of postsynaptic density (PSD), and
signaling processes controlling spine morphology. Many of the signaling pathways ultimately converge on the regulation of the growth and branching of the actin
filament network, which is essential for spine structural remodeling. The proteins encoded by genes from the identified functional cluster (Figure 2) are shown in
yellow, other genes hit by de novo CNV from Levy et al. (2011), in blue, and genes previously implicated or discussed in the context of autism are highlighted using
orange borders. See also Table S4.
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and Cantley, 2006). Another important pathway converging on
mTOR involves MAPK3/ERK, which can be activated by Ras
and NF1. mTOR integrates various inputs from upstream
growth-related pathways, and is also known to regulate dendrite
morphogenesis (Tavazoie et al., 2005).
Although we discussed proteins in the context of dendritic
spine development (Figure 3 and text above), many of the afore-
mentioned proteins also participate in diverse cellular processes
and are reused in the context of axon guidance and neuron
motility (Shen and Cowan, 2010). Such recycling of proteins is
natural because actin network dynamics are essential for such
processes as growth of axonal filopodia, which are used in
searching for growth cone guidance cues (Tessier-Lavigne and
Goodman, 1996). The presence of DCC protein in the identified
network (Figures 2 and 3), also suggests an important role of per-
turbed axonal guidance in autism. AlthoughDCC is also involved
in dendrite development (Suli et al., 2006), this receptor and its
signaling protein, netrin, are primarily essential for guiding axons
to their final destinations (Tessier-Lavigne and Goodman, 1996).Several signaling pathways highlighted in Figure 3, such as the
WNT and reelin pathways, also play prominent roles in neuron
motility (Reiner and Sapir, 2005; Salinas and Zou, 2008). In addi-
tion, several specific proteins, such as PAKs and LIMK, which
regulate the dynamics of actin network, are reused in axonal
morphogenesis. Consequently, malfunction of many proteins
shown in Figure 3 may influence autistic phenotypes through
their role in either dendrite or axon signaling, or possibly a combi-
nation of these processes.
Considering the genes hit by rare de novo variants from the
perspective of the functional molecular network (Figure 3)
allowed us to investigate the likely morphological consequences
ofsomeCNVs.There isgrowingevidence thatchanges indendritic
spine morphology contribute to a number of neurological disor-
ders (Halpain et al., 2005). A decrease in the density of dendritic
spines in regions of the cerebral cortex has been linked to schizo-
phrenia (Blanpied and Ehlers, 2004; Garey et al., 1998; Glantz
and Lewis, 2000). On the other hand, an increase in spine size or
density has been connected to Fragile X syndrome, a disorder
frequently associated with autism (Fiala et al., 2002; KaufmannNeuron 70, 898–907, June 9, 2011 ª2011 Elsevier Inc. 903
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decrease while duplications increase the dosage of the affected
genes, we can infer—based on the structure and regulatory logic
of the functional network in Figure 3—the morphological effects
of 13 gene perturbations on dendritic spines. Specifically, we
found that in 11 out of 13 cases (85%) the gene perturbations
caused by the observed CNV events should increase either
dendritic spine growth or their density (see Table S4). This result
is consistent with recent findings that autistic individuals have
increased spine density in portions of their cerebral cortex (Hutsler
and Zhang, 2010; Woolfrey et al., 2009) and possibly a local brain
overconnectivity (Scott-Van Zeeland et al., 2010).
Overall, the results of this study, the first to our knowledge,
demonstrate that autism-associated rare de novo CNVs,
observed in an unbiased genome-wide study, form a large
and statistically significant functional network responsible for
synaptogenesis, axon guidance, and related molecular pro-
cesses. Therefore, our analysis strongly supports the hypothesis
that autism is primarily a disease of synaptic and neuronal
connectivity malfunction (Zoghbi, 2003). The identified functional
network also reveals a striking genetic complexity of autism. The
genetic events we observe affect the whole arc of molecular
processes essential for proper synapse formation and function.
Similar genetic complexity is already apparent in many cancers
(Cancer Genome Atlas Research Network, 2008; Wood et al.,
2007) and—as we and others believe—will be a hallmark of
many other common human phenotypes and maladies (Wang
et al., 2010). In spite of the observed complexity, our study
provides an important proof of the principle that underlying func-
tional networks responsible for common phenotypes can be
identified by an unbiased analysis of multiple rare genetic pertur-
bations from a large collection of affected individuals.
The functional network presented in Figure 3 contains approx-
imately 70 genes, with about 40% of them perturbed by rare de
novo CNVs observed by Levy et al. (2011). As more genetic data
are analyzed it is likely that the network will grow in size and
significance. Considering that up to a thousand (Sheng and Hoo-
genraad, 2007) distinct proteins are associated with postsyn-
aptic density or that hundreds of different GAPs/GEFs modify
activity of Rho GTPases that are associated with actin network
remodeling, it is likely that many hundreds of genes could ulti-
mately contribute to the autistic phenotype. This estimate, based
on the functional network, is consistent with independent esti-
mates based on recurrent mutations and the overall incidence
of autism in the human population (Zhao et al., 2007; Levy
et al., 2011). Deleterious variants in different genes contributing
to autistic phenotype will almost certainly have different pene-
trance and vulnerabilities. The identification of the complete
set of genes responsible for ASD and understanding their
respective contributions to the phenotype will require analyses
of next generation sequencing data coupled with investigation
of underlying molecular networks.EXPERIMENTAL PROCEDURES
Copy Number Variation (CNV) Data Set
In our analysis, we used the CNV data set obtained in a companion study by
Levy et al. (2011). The data set contained 75 rare de novo CNV events from904 Neuron 70, 898–907, June 9, 2011 ª2011 Elsevier Inc.autistic children. Six very large CNV events, spanning more than 5 mb each,
were not considered in our analysis. The initial CNV dataset contained several
overlapping events, including a set of 10 events all within the region 16p11.2.
Any overlapping CNVs were collapsed into single events to avoid double
counting of genes. We ignored all CNV events that did not contain any anno-
tated human gene based on the NCBI genome build 36. After aforementioned
preprocessing steps, our final CNV set from autistic children contained 47 loci
in total affecting 433 human genes; the average number of genes within each
de novo CNV region was9, with the median of three genes per regions. Levy
et al. (2011) also identified 157 ultrarare inherited CNVs transmitted between
parents and autistic children. Inherited CNVs were classified as ultrarare if
the genes within these events were not affected by any other inherited events
in the study. We applied the same preprocessing steps to these inherited
CNVs, resulting in 156 regions affecting 418 genes.Building the Background Likelihood Network
To perform the NETBAG analysis, we built a background network connecting
all pairs of human genes. Every gene pair in this network was assigned a score
proportional to the log of the ratio of the likelihood that the two genes partici-
pate in the same genetic phenotype to the likelihood that they do not (see
Supplemental Experimental Procedures). Importantly, although similar in spirit
to integrative methods that have been used previously to build functional
networks in several model species (Lee et al., 2004, 2008), the edges in our
network represent the likelihood to participate in the same genetic phenotype
rather than share a functional and molecular interaction.
The likelihood network was build using, as a positive gold standard, the
carefully curated set of human genes compiled recently by Feldman et al.
(2008). This set contains 476 human genes associated with 132 different
genetic phenotypes. As a negative gold standard we used a set of randomly
selected pairs of human genes that are not known to be associated with iden-
tical diseases phenotypes. Importantly, no genes previously implicated in ASD
or any biologically related functions were used in the network construction.
The likelihood score was derived based on naive Bayesian integration of
various descriptors of proteins function: shared GO annotations, participation
in the same KEGG pathways, shared protein domains in InterPro, direct
protein-proteins interactions and shared interaction partners from multiple
databases (BIND, BioGRID, DIP, HPRD, InNetDB, IntAct, BiGG, MINT, and
MIPS), sequence homology between the gene pair calculated using BLAST
(Altschul et al., 1997), and two measures of similarity in coevolutionary
patterns: phylogenetic profile similarity and chromosomal coclustering across
genomes (Chen and Vitkup, 2006). We cross-validated the quality of the back-
ground network by showing that it can be successfully used to prioritize (rank)
genes, located within a chromosomal region, across a variety of genetic
phenotypes (see Supplemental Experimental Procedures for details).Search for High-Scoring Clusters Affected by CNVs
To score a cluster of genes in the network (Figure 1), we combined the scores
for all gene pairs forming the cluster. The direct multiplication of the corre-
sponding likelihoods (network edges) is conceptually equivalent to assuming
that all connections within the cluster are independent; we refer to this proce-
dure as the naive scoring scheme. Second, we applied a simple deweighting
scheme used previously for functional data integration (Lee et al., 2004). For
each gene forming the cluster the deweighting scheme scores the strongest
connection in full, and then decreases the other connections in order of their
strength in a linear fashion (see Supplemental Experimental Procedures).
Effectively, the deweighting scheme gives more weight to strongest gene-
gene connections within the cluster. The detected functional clusters were
significant under both scoring schemes.
A greedy growth algorithm was used to find strongly connected clusters of
genes located within CNV regions (Figure 1). Specifically, the search algorithm
was started from every possible gene in CNV regions, then the gene with the
strongest connection to the first gene was added. At all subsequent iterations,
genes located within CNV regions that most increased the cluster score were
added. Only one (results in Figure 2A) or two (Figure 2B) genes per each CNV
region were allowed in the growing cluster. This growth procedure was run
until no further genes could be added. For each cluster size, clusters obtained
Neuron
Rare CNV Variants in Autism Perturb Synaptogenesisby starting with each gene within CNV regions were compared and the cluster
with the highest score was selected.
Evaluating Significance of Cluster Scores
Wefirst determined the p value for the best cluster at each cluster size; we refer
to this as the local p value. Local p values were calculated based on rerunning
the greedy search algorithm using random human genome regions identical
(either in length or gene number) to those observed by Levy et al. (2011).
Second, to determine the most significant cluster across sizes, we compared
the lowest local p value obtained from the real data, to the distribution of lowest
local p values obtained in the 10,000 trails from the randomized regions. Effec-
tively, this allowed us to assign a p value to our local p value; we refer to this as
the global p value. The global p value is more stringent because it accounts for
multiple hypotheses testing, arising due to different cluster sizes; in our manu-
script we refer to global p value simply as p value. In the aforementioned calcu-
lation of local and global p values, we used two alternative randomization
procedures for human genomic regions: we either preserved the genomic
size of CNVs or the gene counts to the values observed in the real data. All
randomized regions were generated using the NCBI human genome build
36 (hg18). The functional cluster identified in our work was significant under
both randomization schemes (preserving length of CNVs or gene counts)
and cluster scoring methods (naive and deweighted). The p values for different
randomization procedures are given in Table S1.
In addition to the randomization of genomic regionswewanted to ensure that
our results were not due to some general topological features of the back-
ground network. To explore this possibility, we randomly shuffled the back-
ground network while preserving the distribution of connection strengths for
each gene (see Supplemental Experimental Procedures). We then repeated
the NETBAG search using the de novo CNVs from affected children. This
search using the shuffled network identified no significant clusters orGO terms.
Analysis of Genes Contribution to Cluster Score
Contributions of different genes to the score of the identified functional cluster
(Figure 2) vary substantially. To capture that, we devised a formal method to
assign weights to individual genes reflecting their contribution to high scoring
clusters. Themethod is based on two distributions over clusters: p(C), in which
clusters with high scores are assigned a high probability, and a uniform distri-
bution, pu(C), in which all clusters are equally likely (See Supplemental Exper-
imental Procedures). Each individual gene was then given a score equal to the
ratio of the number of clusters that contain the gene sampled from p(C) to the
number sampled from pu(C). As a result, the genes whichweremore frequently
included in high-scoring clusters were assigned higher ratios. We used
Markov-Chain Monte Carlo (MCMC) to sample 5 million clusters from each
of the two distributions.
Calculation of Functional Relationships between the Cluster
and Various GO Categories
To characterize the identified cluster we investigated its interactions with
a collection of a priori defined functional sets of human genes. For this
purpose, we utilized the 1454 gene sets corresponding to the gene ontology
(GO) categories used in the MSigDB database (Subramanian et al., 2005).
Using the background likelihood network, we calculated, for each gene set,
its average interaction to the identified cluster shown in Figure 2. To determine
the significance of the calculated interaction scores we built gene set-specific
background distributions by generating random clusters from the randomized
genomic regions with the same gene count as in Levy et al. (2011). We used the
background distribution to assign an empirical p-value for every gene set, and
then applied the FDR procedure to address the multiple hypotheses involved
in testing all gene sets within the collection (see Supplemental Experimental
Procedures).
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